Chitosan-poly (lactide-co-glycolide) (CS-PLGA) nanoparticles containing metformin HCl: Preparation and in vitro evaluation

Pakistan Journal of Pharmaceutical Sciences

Volumn 27, Issue 6, 2014, Pages 1923-1929

  Gundogdu, Nuran ^a   Cetin, Meltem ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

Author keywords

CS; FT IR; Metformin HCl; Nanoparticles; PLGA

Indexed keywords

CHITOSAN; METFORMIN; NANOCARRIER; POLYGLACTIN; LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; MORPHOLOGY; NANOENCAPSULATION; THERMOGRAPHY; ZETA POTENTIAL; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROSCOPY; MEDICINAL CHEMISTRY; SOLUBILITY;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; LACTIC ACID; METFORMIN; NANOPARTICLES; POLYGLYCOLIC ACID; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84908869416     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Amorim MJ and Ferreira JP (2001). Microparticles for delivering therapeutic peptides and proteins to the lumen of the small intestine. Eur. J. Pharm. Biopharm., 52: 39-44.
2. Banerjee P, Deb J, Roy A, Ghosh A and Chakraborty P (2012). Fabrication and development of pectin micro sphere of metformin hydrochloride. ISRN Pharm., 230621. doi: 10.5402/2012/230621.
3. Barichello JM, Morishita M, Takayama K and Nagai T (1999). Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev. Ind. Pharm., 25(4): 471-476.
4. Cetin M, Atila A, Sahin S and Vural I (2013). Preparation and characterization of metformin hydrochloride loaded-Eudragit®RSPO and Eudragit®RSPO/PLGA nanoparticles. Pharm. Dev. Technol., 18(3): 570-576.
5. Channarong S, Chaicumpa W, Sinchaipanid N and Mitrevej A (2011). Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: The improvement of Peyer's patch targeting using a polyplex-loaded liposomes. AAPS Pharm. Sci. Tech., 12(1): 192-200.
6. Corti G, Cirri M, Maestrelli F, Mennini N and Mura P (2008). Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-β-cyclodextrin. Eur. J. Pharm. Biopharm., 68: 03-309.
7. de Moura MR, Aouada FA and Mattoso LH (2008). Preparation of chitosan nanoparticles using methacrylic acid. J. Colloid Interface Sci., 321 ( 2): 477-483.
8. Emami Riedmaier A, Fisel P, Nies AT, Schaeffeler E and Schwab M (2013). Metformin and cancer: From the old medicine cabinet to pharmacological pitfalls and prospects. Trends Pharmacol. Sci., 34(2): 126-135.
9. Fattal E, Quaglia F, Gupta P and Brazeau G (1999). Biodegradable microparticles for the development of less-painful and less irritating parenterals. In: Gupta P, Brazeau G (editors). Injectable Drug Development: Techniques to reduce pain and irritation. Interpharm Press, Denver, Colorado, pp.355-378.
10. Gazori T, Khoshayand MR, Azizi E, Yazdizade P, Nomani A and Haririan I (2009). Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: Formulation, optimization and in vitro characterization. Carbohydr. Polym., 77 : 599-606.
11. Gelperina S, Kisich K, Iseman MD and Heifets L (2005). The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am. J. Respir. Crit. Care Med., 172: 1487-1490.
12. Gunasekaran S, Natarajan RK, Renganayaki V and Natarajan S (2006). Vibrational spectra and thermodynamic analysis of metformin. IJPAP., 44: 495-500.
13. International Conference on Harmonization (ICH) (1997). Q2b: Validation of analytical procedures: Methodology. US FDA Federal Register, 62: 27463.
14. Islam S (2011). Lipophilic and hydrophilic drug loaded PLA/PLGA in situ implants: Studies on thermal behaviour of drug & polymer and observation of parameters, influencing drug burst release with corresponding effects on loading efficiency & morphology of implants. Int. J. Pharm. Pharm. Sci., 3(Suppl 3): 181-188.
15. Jain SK and Gupta A (2009). Development of gelucire 43/01 beads of metformin hydrochloride for floating delivery. AAPS Pharm. Sci. Tech., 10 ( 4): 1128-1136.
16. Jelvehgari M, Nokhodchi A, Rezapour M and Valizadeh H (2010). Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method. Indian J. Pharm. Sci.,72: 72-78.
17. Kang Y, Yin G, Ouyang P, Huang Z, Yao Y, Liao X, Chen A and Pu X (2008). Preparation of PLLA/PLGA microparticles using solution enhanced dispersion by supercritical fluids (SEDS). J. Colloid Interface Sci., 322(1): 87-94.
18. Khemani M and Sharon M (2012). Encapsulation of berberine in nano-sized PLGA synthesized by emulsification method. ISRN Nanotechnology, doi:10.5402/2012/187354
19. Kilicarslan M and Baykara T (2003). The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int. J. Pharm., 252(1-2): 99-109.
20. Kiremitci-Gumusderelioglu M and Deniz G (1999). Synthesis, characterization and in vitro degradation of poly(DL-lactide)/Poly(DL-lactide-co-glycolide) films, Turk J. Chem., 23: 153-161.
21. Mainardes RM, Gremião MPD and Evangelista RC (2006). Thermoanalytical study of praziquantel-loaded PLGA nanoparticles. Rev. Bras. Cienc. Farm., 42 (4): 523-530.
22. Makadia HK and Siegel SJ (2011). Poly (lactic-coglycolic acid) (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel), 3(3): 1377-1397.
23. Marathe PH, Wen Y, Norton J, Greene DS, Barbhaiya RH and Wilding IR (2000). Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. Br. J. Clin. Pharmacol., 50: 325-332.
24. Mazzarino L, Travelet C, Ortega-Murillo S, Otsuka I, Pignot-Paintrand I, Lemos-Senna E and Borsali R (2012). Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J. Colloid Interface Sci., 370(1): 58-66.
25. Mi FL, Shyu SS, Lin YM, Wu YB, Peng CK and Tsai YH (2003). Chitin/PLGA blend micro spheres as a biodegradable drug delivery system: A new delivery system for protein. Biomaterials., 24(27): 5023-5036.
26. Mouryaa VK, Inamdara NN and Tiwari A (2010). Carboxymethyl chitosan and its applications. Adv. Mat. Lett., 1(1): 11-33.
27. Muthu MS, Rawat MK, Mishra A and Singh S (2009). PLGA nanoparticle formulations of risperidone: Preparation and neuro pharmacological evaluation. Nanomedicine, 5: 323-333.
28. Pandit V, Pai RS, Yadav V, Devi K, Surekha BB, Inamdar MN and Suresh S (2013). Pharmacokinetic and pharmacodynamic evaluation of floating microspheres of metformin hydrochloride. Drug Dev. Ind. Pharm., 39(1): 117-127.
29. Parveen S and Sahoo SK (2011). Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur. J. Pharmacol., 670: 372-83.
30. Ravi Kumar M, Bakowsky U and Lehr C (2004). Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials, 25 : 1771-1777.
31. Said SS, Aloufy AK, El-Halfawy OM, Boraei NA and El-Khordagui LK (2011). Anti-microbial PLGA ultrafine fibers: Interaction with wound bacteria. Eur. J. Pharm. Biopharm., 79(1): 108-118.
32. 4-gold-chitosan nanostructure. J. Nanobiotechnology, 10: 3. doi: 10.1186/1477-3155-10-3.
33. Shabir GA (2003). Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US food and drug Administration, the US Pharmacopeia and the International Conference on Harmonization. J. Chromatogr. A., 987(1-2): 57-66.
34. Song X, Zhao Y, Hou S, Xu F, Zhao R, He J, Cai Z, Li Y and Chen Q (2008a). Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur. J. Pharm. Biopharm., 69: 445-453.
35. Song X, Zhao Y, Wu W, Bi Y, Cai Z and Chen Q, Li Y and Hou S (2008b). PLGA nanoparticles simultaneously loaded with vincristine sulphate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int. J. Pharm., 350(1-2): 320-329.
36. Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z and Zelefsky MJ (2013). Metformin and prostate cancer: Reduced development of castration-resistant disease and prostate cancer mortality. Eur. Urol., 63 (4): 709-716.
37. Sweetman S (2007). (Editor). Martindale: The Complete Drug Reference. Pharmaceutical Press, Electronic version, London.
38. Tuncay M, Calis S, Kas HS, Ercan MT, Peksoy I and Hincal AA (2000). Diclofenac sodium incorporated PLGA (50:50) microspheres: Formulation considerations and in vitro in vivo evaluation. Int. J. Pharm., 195 : 179-188.
39. Wang Q, Jamal S, Detamore MS and Berkland C (2011). PLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells. J. Biomed. Mater. Res. A., 96: 520-527.